Brown J H, Hunt L P, Vites N P, Short C D, Gokal R, Mallick N P
Department of Renal Medicine, Manchester Royal Infirmary, UK.
Nephrol Dial Transplant. 1994;9(8):1136-42. doi: 10.1093/ndt/9.8.1136.
Patients with chronic renal failure show an excess mortality from cardiovascular disease (CVD). Over a 4-year period (1983-1986) we have prospectively studied 305 patients (177 men, 128 women) from a geographically constrained population entering a renal replacement therapy (RRT) programme. The development of new cardiovascular events and patient survival have been documented up to the end of 1990. We have determined the incidence of CVD amongst the patients compared to the general population of the region and assessed the predictive value for future cardiovascular events of risk factors present at the start of RRT. One hundred and fourteen patients experienced a new cardiovascular event. One hundred and fifteen patients died, 89 from CVD. Stratification by age and sex identified diabetes, previous coronary heart disease, and cardiomegaly to be significantly associated with an increased risk of a cardiovascular event, and diabetes, previous coronary heart disease, and accelerated hypertension to be significantly associated with an increased risk of cardiovascular death. Mortality from CVD was 10.1 times that of the corresponding general population, and was increased 44 times for patients with diabetes. Duration of RRT did not influence mortality rates. This excessive early mortality has significant implications for RRT programmes and further research is necessary to identify individuals at risk and the modifiable risk factors that could receive targeted interventional therapy.
慢性肾衰竭患者心血管疾病(CVD)死亡率过高。在1983年至1986年的4年期间,我们对来自一个地理范围有限的人群中进入肾脏替代治疗(RRT)项目的305名患者(177名男性,128名女性)进行了前瞻性研究。截至1990年底,记录了新的心血管事件的发生情况和患者的生存情况。我们确定了该患者群体中CVD的发病率,并与该地区的普通人群进行了比较,同时评估了RRT开始时存在的危险因素对未来心血管事件的预测价值。114名患者发生了新的心血管事件。115名患者死亡,其中89例死于CVD。按年龄和性别分层显示,糖尿病、既往冠心病和心脏肥大与心血管事件风险增加显著相关,糖尿病、既往冠心病和加速性高血压与心血管死亡风险增加显著相关。CVD死亡率是相应普通人群的10.1倍,糖尿病患者的死亡率则增加了44倍。RRT的持续时间并未影响死亡率。这种过高的早期死亡率对RRT项目具有重要意义,有必要进一步开展研究,以确定高危个体以及可接受针对性干预治疗的可改变危险因素。